Rankings / Muscle Building

Ostarine (MK-2866 / enobosarm)

Muscle Building · SARM

Tier C+

anabolicbannedresearch-only
5.3 / 10
Tier C+
Ev 6.0 Bn 5.0 Sf 5.0 Ax 4.0

What this is

Most studied SARM clinically. Veru ARES Ph3 in AR+/ER+ breast cancer (2024). FDA has warned against SARMs in supplements multiple times. 2025 Grassley/Whitehouse SARMs Control Act bill introduced again; previous versions (2018, 2019) did not pass. Despite marketing, not 'side-effect-free' vs steroids.

Mechanism

Selective androgen receptor modulator; tissue-selective AR agonist (muscle/bone agonist, lesser prostate activity); developed by GTx for muscle wasting and now Veru for breast cancer (ARES trial)

Dose & route

Typical illicit: 10-25 mg/day PO for 8-12 weeks

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.